Send feedback

CBL p.Ile199Val

c.595A>G · rs397517082 · VCV45210

Conflicting classifications of pathogenicity Conflicting submitters
Classification
Conflicting classifications of pathogenicity
ClinVar
Review
Conflicting submitters ★☆☆☆
ClinVar · 7 submitters
AlphaMissense
likely benign
0.0792 · ACMG-weighted
gnomAD v4.1
Rare
very rare (popmax 0.00167%, amr)
Missense predictors
0/2 damaging
AlphaMissense, SaProt · REVEL indeterminate
Conditions
2
Cardiovascular phenotype

Computational evidence

Protein change
AlphaMissense0.0792likely benign
REVEL0.446indeterminate
SaProtLLR -9.74tolerated
⇒ AlphaMissense and SaProt both call this tolerated; REVEL is indeterminate.
Splicing
SpliceAIΔ0.88acceptor gain · deltas
PangolinΔ0.25gain · loss 0.01 · agrees with SpliceAI · independent
Constraint at this position
ConservationphyloP 4GERP 1.9, phastCons 1
Regional constrainto/e 0.60unconstrained · MANE · 45 kb · p 4.6e-13 · regional, not allelic
Overall
CADD34.0PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.00167% Admixed American · 1/60,002 alleles
Filtering AF 0.000292% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.000211%
Overall 0.00155% 25/1,613,772 alleles · very rare exomes 24/1,461,574 · genomes 1/152,198 · joint denominator
Ancestry group Frequency 1 in
Ashkenazi Jewishnot grpmax-eligible 0.0439% 2,277
Remaining individualsnot grpmax-eligible 0.0032% 31,242
Admixed Americangrpmax 0.00167% 60,002
South Asian 0.0011% 91,078
European (non-Finnish) 0.000678% 147,473

Ashkenazi Jewish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
CBL
Protein
p.Ile199Val
Coding
c.595A>G
MANE Select
NM_005188
dbSNP
rs397517082
Type
single nucleotide variant
Location
chr11:119273872 (GRCh38)
Gene constraint
LOEUF 0.622 · pLI <0.01 · ClinGen HI 0/3 (gnomAD)
Structure
AlphaFold pLDDT 64.27 · 34 PDB
Residue 199
the cbl-ptb domain; the 'sufficient for interaction with ephb1' region; the 'ef-hand-like' region; a β-strand
Full CBL gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/cbl-p-ile199val (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown